Northern Trust’s Pyxis Oncology PYXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Sell |
102,216
-271,500
| -73% | -$299K | ﹤0.01% | 4087 |
|
|
2025
Q1 | $366K | Sell |
373,716
-4,870
| -1% | -$4.77K | ﹤0.01% | 3703 |
|
|
2024
Q4 | $591K | Sell |
378,586
-15,449
| -4% | -$24.1K | ﹤0.01% | 3597 |
|
|
2024
Q3 | $1.45M | Buy |
394,035
+265,639
| +207% | +$975K | ﹤0.01% | 3182 |
|
|
2024
Q2 | $425K | Buy |
128,396
+67,162
| +110% | +$222K | ﹤0.01% | 3567 |
|
|
2024
Q1 | $261K | Buy |
61,234
+951
| +2% | +$4.05K | ﹤0.01% | 3801 |
|
|
2023
Q4 | $109K | Buy |
60,283
+7,537
| +14% | +$13.6K | ﹤0.01% | 4095 |
|
|
2023
Q3 | $105K | Buy |
52,746
+5,353
| +11% | +$10.7K | ﹤0.01% | 4002 |
|
|
2023
Q2 | $121K | Buy |
47,393
+15,886
| +50% | +$40.7K | ﹤0.01% | 3985 |
|
|
2023
Q1 | $126K | Buy |
31,507
+5,109
| +19% | +$20.5K | ﹤0.01% | 4021 |
|
|
2022
Q4 | $35.4K | Hold |
26,398
| – | – | ﹤0.01% | 4367 |
|
|
2022
Q3 | $52K | Buy |
26,398
+8,656
| +49% | +$17.1K | ﹤0.01% | 4313 |
|
|
2022
Q2 | $42K | Sell |
17,742
-70,587
| -80% | -$167K | ﹤0.01% | 4455 |
|
|
2022
Q1 | $357K | Sell |
88,329
-906
| -1% | -$3.66K | ﹤0.01% | 3875 |
|
|
2021
Q4 | $979K | Buy |
+89,235
| New | +$979K | ﹤0.01% | 3546 |
|